Phase III trial results of the R21/Matrix-M vaccine developed by Oxford University and Serum Institute of India Pvt Ltd, leveraging Novavax's Matrix-M adjuvant, has confirmed high efficacy and supported regulatory approvals ...
Feb 2, 2024
0
32
Most people with schizophrenia have extensive impairment of memory, including prospective memory, which is the ability to remember to perform future activities. Results from a randomized clinical trial published in Neuropsychopharmacology ...
Dec 6, 2023
0
14
A team of medical researchers from Shanghai Jiaotong University School of Medicine, Central South University and the Second Affiliated Hospital of Anhui Medical University, all in China, has found evidence suggesting that ...
Since the start of the COVID pandemic, there has been more attention given to problems of mental ill-health including depression than ever before. A new therapeutic option, especially for depression, transcranial magnetic ...
Aug 29, 2023
0
22
More than 14,490 people in the U.S. will be diagnosed with glioblastoma in 2023, according to the National Brain Tumor Society, and 10,000 people in the U.S. will die of the disease. The five-year survival rate is 6.9%, and ...
Jul 22, 2023
0
2
A Rochester Institute of Technology scientist helped develop a new mathematical model that could aid doctors and patients assessing different approaches for treating metastatic cancer. Assistant Professor Nourridine Siewe ...
Nov 4, 2022
0
2
Clinical trials are critical to understanding the benefits of new treatments and medical therapies, but researchers say people who design and run clinical trials need to lift their game when it comes to recording and reporting ...
Oct 27, 2022
0
16
Breast cancer is the leading cause of cancer-associated death for women worldwide. While chemotherapy is the mainstream treatment for breast cancer, more than 50% of women undergoing chemotherapy will experience at least ...
May 3, 2022
0
77
A team of researchers at the University of Pennsylvania has found that administration of a drug currently used to reduce cholesterol levels in the bloodstream can reduce the risk of developing proliferative diabetic retinopathy ...
In the summer of 2020, Texas Tech University's Office of Research Commercialization filed a patent application and applied for the COVID-19 Prioritized Examination Pilot Program with the U.S. Patent and Trade Office.
Mar 28, 2022
0
6
